Ischemic stroke in cancer patients: possibilities of reperfusion therapy in elderly patients

Globally, stroke and malignancies represent a major public health burden. Cancer and stroke are two clinical manifestations that are related: cancer patients have twice the risk of stroke than the general population [1]. Types of cancer most commonly associated with ischemic stroke are lung cancer, pancreatic cancer, breast cancer and prostate cancer [2]. An analysis of patients with ischemic stroke and concomitant cancer who underwent inpatient treatment at the regional vascular center in Botkin Hospital. A total of 199 patients with ischemic stroke and malignancy were analyzed. 68 patients received reperfusion therapy and 131 patients did not receive reperfusion therapy. As a result of the analysis, it was concluded that reperfusion therapy is possible and necessary for patients with malignant tumors. The risk of developing extracranial hemorrhages associated with the oncological process is extremely low, and the development of intracranial hemorrhagic complications does not significantly worsen the outcome of the disease. The severity of stroke in the presence of cancer was for the most part due to the stroke itself, its size and location, and depended less on the stage of cancer.

1. Salazar-Camelo RA, Moreno-Vargas EA, Cardona AF, Bayona-Ortiz HF. Ischemic stroke: A paradoxical manifestation of cancer. Crit Rev Oncol Hematol. 2021 Jan; 157: 103181. DOI: 10.1016/j.critrevonc.2020.103181. Epub 2020 Nov 16. PMID: 33264715.

2. Oh Young Bang, Jong-Won Chung, Mi Ji Lee, Woo-Keun Seo, Gyeong-Moon Kim, Myung-Ju Ahn Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms. Journal of Stroke Pub Date: 2020–01–31, 1–10

3. Zaorsky NG, Zhang Y, Tchelebi LT et al. Stroke among cancer patients. Nat Commun 2019; 10: 5172.

4. Dardiotis E, Aloizou AM, Markoula S et al. Cancer-associated stroke: pathophysiology, detection and management (Review). Int J. Oncol. 2019; 54: 779–796.

5. Pana TA, Mohamed MO, Mamas MA, et al. Prognosis of acute ischaemic stroke patients with cancer: a national inpatient sample study. Cancers(Basel) 2021; 13.

6. Navi BB, Howard G, Howard VJ, et al. New diagnosis of cancer and the risk of subsequent cerebrovascular events. Neurology 2018; 90: e2025–e2033.

7. Kneihsl M, Enzinger C, Wünsch G, Khalil M, Culea V, Urbanic-Purkart T, Payer F, Niederkorn K, Fazekas F, Gattringer T. Poor short-term outcome in patients with ischaemic stroke and active cancer. J. Neurol. 2016; 263: 150–156. DOI: 10.1007/s00415–015–7954–6

8. Newton HB. Neurologic complications of systemic cancer. Am Fam Physician. 1999; 59: 878–886.

9. Arboix A. Cerebrovascular disease in the cancer patient. Rev Neurol. 2000; 31: 1250–1252. In Spanish.

10. Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: A review. Acta Neurol Scand. 2009; 119: 1–16. DOI: 10.1111/j.1600–0404.2008.01059.x

11. Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J. Stroke Cerebrovasc Dis. 2008;17: 169–174. DOI: 10.1016/j.jstrokecerebrovasdis.2008.01.007

12. Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M, Gozes I, Bogdanos DP, Spandidos DA, Mitsias PD, Tsatsakis A. Cancer-associated stroke: Pathophysiology, detection and management (Review). Int J. Oncol. 2019 Mar; 54 (3): 779–796. DOI: 10.3892/ijo.2019.4669

13. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014: CD 000213.

14. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012 Jun 23; 379 (9834): 2364–72.

15. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363: 768–774. DOI: 10.1016/S0140–6736(04)15692–4

16. Shamalov N. A., Khasanova D. R., Stakhovskaya L. V., Voznyuk I. A., Yanishevsky S. N., Vinogradov O. I., Kharitonova T. V., Alekyan B. G., Kandyba D. V., Savello A. V. Reperfusion therapy for ischemic stroke. Clinical protocol. M., 2019. 80 p. (In Russ.).

17. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul; 20 (7): 864–70. DOI: 10.1161/01.str.20.7.864. PMID: 2749846.